{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T20:50:22Z","timestamp":1789159822518,"version":"build-2803163510"},"reference-count":34,"publisher":"Impact Journals, LLC","issue":"28","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncotarget"],"published-print":{"date-parts":[[2018,4,13]]},"DOI":"10.18632\/oncotarget.24701","type":"journal-article","created":{"date-parts":[[2018,4,13]],"date-time":"2018-04-13T13:50:43Z","timestamp":1523627443000},"page":"19613-19622","source":"Crossref","is-referenced-by-count":10,"title":["Indolent lymphoma with composite histology and simultaneous transformation at initial diagnosis exhibit clinical features similar to <i>de novo<\/i> diffuse large B-cell lymphoma"],"prefix":"10.18632","volume":"9","author":[{"given":"Hanno","family":"Witte","sequence":"first","affiliation":[{"name":"Department of Hematology and Oncology, University Hospital of Schleswig-Holstein, Campus Luebeck, Luebeck, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harald","family":"Biersack","sequence":"additional","affiliation":[{"name":"Department of Hematology and Oncology, University Hospital of Schleswig-Holstein, Campus Luebeck, Luebeck, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Svenja","family":"Kopelke","sequence":"additional","affiliation":[{"name":"Department of Hematology and Oncology, University Hospital of Schleswig-Holstein, Campus Luebeck, Luebeck, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dirk","family":"Rades","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, University Hospital of Schleswig-Holstein, Campus Luebeck, Luebeck, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hartmut","family":"Merz","sequence":"additional","affiliation":[{"name":"H\u00e4matopathologie L\u00fcbeck, Reference Center for Lymph Node Pathology and Hematopathology, L\u00fcbeck, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veronica","family":"Bernard","sequence":"additional","affiliation":[{"name":"H\u00e4matopathologie L\u00fcbeck, Reference Center for Lymph Node Pathology and Hematopathology, L\u00fcbeck, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hendrik","family":"Lehnert","sequence":"additional","affiliation":[{"name":"Department of Hematology and Oncology, University Hospital of Schleswig-Holstein, Campus Luebeck, Luebeck, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niklas","family":"Gebauer","sequence":"additional","affiliation":[{"name":"Department of Hematology and Oncology, University Hospital of Schleswig-Holstein, Campus Luebeck, Luebeck, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"7892","published-online":{"date-parts":[[2018,4,13]]},"reference":[{"key":"1","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.1002\/1097-0142(197604)37:4<1923::AID-CNCR2820370443>3.0.CO;2-D","article-title":"The natural history of nodular lymphoma","volume":"37","author":"Long","year":"1976","journal-title":"Cancer"},{"key":"2","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1002\/1097-0142(197908)44:2<645::AID-CNCR2820440234>3.0.CO;2-Y","article-title":"Histological transformation of non-Hodgkin's lymphoma: a prospective study","volume":"44","author":"Stansfeld","year":"1979","journal-title":"Cancer"},{"key":"3","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1182\/blood-2016-01-643569","article-title":"The 2016 revision of the World Health Organization classification of lymphoid neoplasms","volume":"127","author":"Jaffe","year":"2016","journal-title":"Blood"},{"key":"4","doi-asserted-by":"crossref","first-page":"1726","DOI":"10.1200\/JCO.1995.13.7.1726","article-title":"Long-term survival after histologic transformation of low-grade follicular lymphoma","volume":"13","author":"Horning","year":"1995","journal-title":"J Clin Oncol"},{"key":"5","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1200\/JCO.1997.15.4.1587","article-title":"Incidence, predictive factors, and outcome of lymphoma transformation in follicular lymphoma patients","volume":"15","author":"Coiffier","year":"1997","journal-title":"J Clin Oncol"},{"key":"6","doi-asserted-by":"crossref","first-page":"3272","DOI":"10.1200\/JCO.2012.48.3990","article-title":"Rates and outcomes of follicular lymphoma transformation in the immunochemotherapy era: a report from the University of Iowa\/MayoClinic Specialized Program of Research Excellence Molecular Epidemiology Resource","volume":"31","author":"Cerhan","year":"2013","journal-title":"J Clin Oncol"},{"key":"7","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1111\/j.1365-2141.2012.09054.x","article-title":"Incidence, risk factors and outcome of histological transformation in follicular lymphoma","volume":"157","author":"Zucca","year":"2012","journal-title":"Br J Haematol"},{"key":"8","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1080\/10428190903093815","article-title":"Predicting transformation in follicular lymphoma","volume":"50","author":"de Boer","year":"2009","journal-title":"Leuk Lymphoma"},{"key":"9","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1093\/annonc\/mdh406","article-title":"Predictive value of Follicular Lymphoma International Prognostic Index (FLIPI) in patients with follicular lymphoma at first progression","volume":"15","author":"Campo","year":"2004","journal-title":"Ann Oncol"},{"key":"10","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1200\/JCO.2012.44.0693","article-title":"Autologous and allogeneic stem-cell transplantation for transformed follicular lymphoma: a report of the Canadian blood and marrow transplant group","volume":"31","author":"Xenocostas","year":"2013","journal-title":"J Clin Oncol"},{"key":"11","doi-asserted-by":"crossref","first-page":"2575","DOI":"10.1200\/JCO.2015.65.7163","article-title":"Risk Factors and Outcomes for Patients With Follicular Lymphoma Who Had Histologic Transformation After Response to First-Line Immunochemotherapy in the PRIMA Trial","volume":"34","author":"Caballero","year":"2016","journal-title":"J Clin Oncol"},{"key":"12","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.clml.2012.07.003","article-title":"Superior long-term outcome of patients with early transformation of non-Hodgkin lymphoma undergoing stem cell transplantation","volume":"12","author":"Savani","year":"2012","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"13","doi-asserted-by":"crossref","first-page":"2799","DOI":"10.1093\/annonc\/mdx407","article-title":"Clinicobiological features and prognostic impact of diffuse large B-cell lymphoma component in the outcome of patients with previously untreated follicular lymphoma","volume":"28","author":"Colomer","year":"2017","journal-title":"Ann Oncol"},{"key":"14","article-title":"Real world data on rituximab maintenance therapy after frontline immunochemotherapy in grade 1-3a follicular lymphoma","author":"El-Galaly","year":"2017","journal-title":"Br J Haematol"},{"key":"15","doi-asserted-by":"crossref","first-page":"2373","DOI":"10.1200\/JCO.2009.26.2493","article-title":"Standard International prognostic index remains a valid predictor of outcome for patients with aggressive CD20+ B-cell lymphoma in the rituximab era","volume":"28","author":"Loeffler","year":"2010","journal-title":"J Clin Oncol"},{"key":"16","doi-asserted-by":"crossref","first-page":"3109","DOI":"10.1093\/annonc\/mdx020","article-title":"Newly diagnosed and relapsed follicular lymphoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up","volume":"28","author":"Ladetto","year":"2017","journal-title":"Ann Oncol"},{"key":"17","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1182\/blood-2015-01-621375","article-title":"Outcomes of transformed follicular lymphoma in the modern era: a report from the National LymphoCare Study (NLCS)","volume":"126","author":"Bartlett","year":"2015","journal-title":"Blood"},{"key":"18","doi-asserted-by":"crossref","first-page":"5165","DOI":"10.1200\/JCO.2008.16.0283","article-title":"Population-based analysis of incidence and outcome of transformed non-Hodgkin's lymphoma","volume":"26","author":"Connors","year":"2008","journal-title":"J Clin Oncol"},{"key":"19","doi-asserted-by":"crossref","first-page":"2426","DOI":"10.1200\/JCO.2006.09.3260","article-title":"Risk and clinical implications of transformation of follicular lymphoma to diffuse large B-cell lymphoma","volume":"25","author":"Lister","year":"2007","journal-title":"J Clin Oncol"},{"key":"20","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1200\/JCO.1983.1.1.11","article-title":"Histologic conversion in the non-Hodgkin's lymphomas","volume":"1","author":"Rosenberg","year":"1983","journal-title":"J Clin Oncol"},{"key":"21","first-page":"953","article-title":"Transformed follicular lymphoma: the 25-year experience of a UK provincial lymphoma treatment centre","volume":"20","author":"Hancock","year":"2008","journal-title":"Oncol Rep"},{"key":"22","doi-asserted-by":"crossref","first-page":"2363","DOI":"10.1182\/blood-2002-07-2298","article-title":"A significant diffuse component predicts for inferior survival in grade 3 follicular lymphoma, but cytologic subtypes do not predict survival","volume":"101","author":"Armitage","year":"2003","journal-title":"Blood"},{"key":"23","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1111\/bjh.14688","article-title":"Risk of histological transformation and therapy-related myelodysplasia\/acute myeloid leukaemia in patients receiving radioimmunotherapy for follicular lymphoma","volume":"178","author":"Colgan","year":"2017","journal-title":"Br J Haematol"},{"key":"24","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1111\/j.1365-2141.2011.08942.x","article-title":"Clinical significance of the WHO grades of follicular lymphoma in a population-based cohort of 505 patients with long follow-up times","volume":"156","author":"Sander","year":"2012","journal-title":"Br J Haematol"},{"key":"25","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1038\/35000501","article-title":"Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling","volume":"403","author":"Marti","year":"2000","journal-title":"Nature"},{"key":"26","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.1056\/NEJMoa012914","article-title":"The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma","volume":"346","author":"Averett","year":"2002","journal-title":"N Engl J Med"},{"key":"27","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1097\/MOH.0000000000000255","article-title":"The routes for transformation of follicular lymphoma","volume":"23","author":"Fitzgibbon","year":"2016","journal-title":"Curr Opin Hematol"},{"key":"28","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.celrep.2013.12.027","article-title":"Genetics of follicular lymphoma transformation","volume":"6","author":"Murty","year":"2014","journal-title":"Cell Rep"},{"key":"29","doi-asserted-by":"crossref","first-page":"1951","DOI":"10.1182\/blood-2007-11-124560","article-title":"S(mu) mutation patterns suggest different progression pathways in follicular lymphoma: early direct or late from FL progenitor cells","volume":"112","author":"Bastard","year":"2008","journal-title":"Blood"},{"key":"30","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1200\/JCO.1989.7.11.1630","article-title":"Report of a committee convened to discuss the evaluation and staging of patients with Hodgkin's disease: Cotswolds meeting","volume":"7","author":"Tubiana","year":"1989","journal-title":"J Clin Oncol"},{"key":"31","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.1182\/blood-2006-08-038257","article-title":"The revised International Prognostic Index (R-IPI) is a better predictor of outcome than the standard IPI for patients with diffuse large B-cell lymphoma treated with R-CHOP","volume":"109","author":"Connors","year":"2007","journal-title":"Blood"},{"key":"32","doi-asserted-by":"crossref","first-page":"5234","DOI":"10.1200\/JCO.2006.07.5671","article-title":"Clinicopathologic characteristics and outcome of diffuse large B-cell lymphomas presenting with an associated low-grade component at diagnosis","volume":"24","author":"Salles","year":"2006","journal-title":"J Clin Oncol"},{"key":"33","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1182\/blood-2003-05-1545","article-title":"Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray","volume":"103","author":"Smith","year":"2004","journal-title":"Blood"},{"key":"34","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1200\/JCO.2006.09.2403","article-title":"Revised response criteria for malignant lymphoma","volume":"25","author":"Lister","year":"2007","journal-title":"J Clin Oncol"}],"container-title":["Oncotarget"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.24701","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,9]],"date-time":"2020-05-09T16:26:57Z","timestamp":1589041617000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.24701"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4,13]]},"references-count":34,"journal-issue":{"issue":"28","published-print":{"date-parts":[[2018,4,13]]}},"alternative-id":["24701","29731969"],"URL":"https:\/\/doi.org\/10.18632\/oncotarget.24701","relation":{},"ISSN":["1949-2553"],"issn-type":[{"value":"1949-2553","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,4,13]]}}}